Dwight Moxie, SVP, GC & Secretary at Revance Therapeutics, Inc. (RVNC), sold 11,000 shares at $27.07 ($298K) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market sale of $298k RVNC by SVP, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RVNC | SELL | 2023-05-16 | $1.5M | — | Filing → |
| RVNC | SELL | 2023-03-09 | $1.2M | — | Filing → |
| RVNC | SELL | 2021-09-28 | $50K | — | Filing → |